207_Combined course Presentations
Take Home Message for Oligometastatic NSCLC
A combination of chemo or immunotherapy + local therapies could probably improve patients outcome in this setting, at least in selected subgroups
Phase III trials are warranted to confirm the effectiveness of a multimodality approach in this setting.
In the meantime…
Unity Makes Strength…!
Made with FlippingBook